The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heuertz, R. M.
Right arrow Articles by Webster, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heuertz, R. M.
Right arrow Articles by Webster, R. O.

The Journal of Immunology, Vol 156, Issue 9 3412-3417, Copyright © 1996 by American Association of Immunologists

ARTICLES

Peptides derived from C-reactive protein inhibit neutrophil alveolitis

RM Heuertz, N Ahmed and RO Webster
Department of Medicine, Section of Pulmonary and Critical Care, University of Chicago, IL 60637, USA.

C-reactive protein (CRP) is the classic acute phase reactant in humans, with serum levels elevated up to 1000-fold after the onset of inflammation. CRP inhibits chemotaxis of complement (C5a)-, LTB4-, IL-8- , and FMLP-stimulated neutrophils in vitro, and rabbits and transgenic mice with elevated serum CRP levels exhibit diminished neutrophil infiltration and vascular permeability in models of chemotactic factor- induced alveolitis. To evaluate the mechanism of CRP inhibition on chemoattractant-induced neutrophil inflammation in vivo, experiments were performed in mice infused with peptides of human CRP shown to inhibit C5a- and FMLP-stimulated neutrophil chemotaxis in vitro. After direct tracheal instillation of FMLP, mice previously injected via the retro-orbital plexus with CRP peptide 77-82 or 201-206 showed significant reductions (up to 90%) of neutrophils in the bronchoalveolar lavage fluid compared with vehicle-treated mice. Both CRP peptides also significantly (up to 55%) inhibited the increase in alveolar total protein levels. Control injections of native rabbit CRP (3 microM) inhibited neutrophil influx by 93% and protein leak by 55% in mice intratracheally instilled with FMLP. Despite similar levels of inhibition, approximately 10-fold more peptide by weight than native CRP was required. These data suggest that CRP degradation products at sites of tissue injury, in particular CRP peptides 77-82 and 201-206, are anti-inflammatory and can diminish lung injury by a reduction in neutrophil influx and protein leakage into alveoli following FMLP- induced inflammation.


This article has been cited by other articles:


Home page
 ChestHome page
R. E. Walter, J. B. Wilk, M. G. Larson, R. S. Vasan, J. F. Keaney Jr, I. Lipinska, G. T. O'Connor, and E. J. Benjamin
Systemic Inflammation and COPD: The Framingham Heart Study
Chest, January 1, 2008; 133(1): 19 - 25.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Nishimura, T. Myles, A. M. Piliposky, P. N. Kao, G. J. Berry, and L. L. K. Leung
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo
Blood, March 1, 2007; 109(5): 1992 - 1997.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. E. Carpagnano, P. J. Barnes, D. M. Geddes, M. E. Hodson, and S. A. Kharitonov
Increased Leukotriene B4 and Interleukin-6 in Exhaled Breath Condensate in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1109 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. ANGRILL, C. AGUSTI, R. DE CELIS, X. FILELLA, A. RANO, M. ELENA, J. P. DE LA BELLACASA, A. XAUBET, and A. TORRES
Bronchial Inflammation and Colonization in Patients with Clinically Stable Bronchiectasis
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1628 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Torzewski, C. Rist, R. F. Mortensen, T. P. Zwaka, M. Bienek, J. Waltenberger, W. Koenig, G. Schmitz, V. Hombach, and J. Torzewski
C-Reactive Protein in the Arterial Intima : Role of C-Reactive Protein Receptor-Dependent Monocyte Recruitment in Atherogenesis
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2094 - 2099.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
S. A. Jones, D. Novick, S. Horiuchi, N. Yamamoto, A. J. Szalai, and G. M. Fuller
C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
J. Exp. Med., February 1, 1999; 189(3): 599 - 604.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Ayroldi, O. Zollo, L. Cannarile, F. D' Adamio, U. Grohmann, D. V. Delfino, and C. Riccardi
Interleukin-6 (IL-6) Prevents Activation-Induced Cell Death: IL-2-Independent Inhibition of Fas/fasL Expression and Cell Death
Blood, December 1, 1998; 92(11): 4212 - 4219.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Zhong, Q. Zen, J. Tebo, K. Schlottmann, M. Coggeshall, and R. F. Mortensen
Effect of Human C-Reactive Protein on Chemokine and Chemotactic Factor-Induced Neutrophil Chemotaxis and Signaling
J. Immunol., September 1, 1998; 161(5): 2533 - 2540.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. CASALS, A. VARELA, M. L. F. RUANO, F. VALIÑO, J. PÉREZ-GIL, N. TORRE, E. JORGE, F. TENDILLO, and J. L. CASTILLO-OLIVARES
Increase of C-Reactive Protein and Decrease of Surfactant Protein A in Surfactant after Lung Transplantation
Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 43 - 49.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.